Embedded fiber
Confirm polymer or other carrier, loading basis, fiber specification, and the downstream spinning route.
Independent ingredient-material guide
Separate the mineral formulation, carrier route, textile construction, test specimen, study population, protocol, and measured endpoint before carrying any infrared statement into a product brief.
Material route map
CELLIANT is an ingredient technology owned by Hologenix, LLC, not a finished-goods line offered by this guide. These checkpoints organize due diligence without implying supply, authorization, or current availability.
Confirm polymer or other carrier, loading basis, fiber specification, and the downstream spinning route.
Record blend, yarn construction, denier or count, and whether evidence matches the planned fabric.
Keep knit, weave, GSM, finish, color, and proximity-to-skin conditions with the product question.
Do not transfer embedded-route durability language to a surface print without route-specific testing.
Evidence hierarchy
Carrier composition and XRF or ash evidence may help confirm ingredient presence; they do not establish a health outcome.
Emissivity belongs to a stated sample, wavelength range, temperature, and comparison protocol.
TcPO2, HSI, sleep, strength, or recovery observations remain tied to study design and population.
The FDA has not approved or designated CELLIANT products for any purpose and has not determined or endorsed their stated use or benefits.
The official general-wellness language concerns temporarily promoting increased local circulation at the site of application in healthy individuals. It is not a disease-treatment promise.
Identify the exact carrier, loading, construction, application, target market, protocol, population, and endpoint. Then request current documentation from Hologenix or the relevant authorized party.